Bioextrax AB (publ) (STO:BIOEX)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.580
+0.040 (1.57%)
Jun 3, 2026, 5:15 PM CET
Market Cap120.91M +20.7%
Revenue (ttm)1.33M +39.7%
Net Income-18.05M
EPS-0.44
Shares Out 47.60M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume39,117
Open2.480
Previous Close2.540
Day's Range2.430 - 2.580
52-Week Range1.600 - 4.000
Beta1.57
Analystsn/a
Price Targetn/a
Earnings DateJun 5, 2026

About Bioextrax AB

Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids, as well as microfibers from feathers. Bioextrax AB (publ) was incorporated in 2014 and is based in Lund, Sweden. [Read more]

Founded 2014
Employees 14
Stock Exchange Nasdaq Stockholm
Ticker Symbol BIOEX
Full Company Profile

Financial Performance

In 2025, Bioextrax AB's revenue was 1.24 million, an increase of 22.55% compared to the previous year's 1.01 million. Losses were -17.71 million, 2.12% more than in 2024.

Financial Statements

News

Bioextrax AB Quarterly report: Q1 2026

Bioextrax AB has published its Q1 2026 quarterly earnings report on May 22, 2026.

12 days ago - Filings

Bioextrax AB Quarterly report: Q4 2025

Bioextrax AB has published its Q4 2025 quarterly earnings report on February 24, 2026.

3 months ago - Filings

Bioextrax AB Annual report: Q4 2025

Bioextrax AB has published its Q4 2025 annual report on February 24, 2026.

3 months ago - Filings

Bioextrax AB Quarterly report: Q3 2025

Bioextrax AB has published its Q3 2025 quarterly earnings report on November 26, 2025.

6 months ago - Filings

Bioextrax AB Quarterly report: Q2 2025

Bioextrax AB has published its Q2 2025 quarterly earnings report on August 27, 2025.

10 months ago - Filings